Clover Health Investments, Corp. (CLOV) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Clover Health Investments, Corp. (CLOV:NASDAQ), powered by AI.

Current Price
$4.73
P/E Ratio
-28.3
Market Cap
2.4B
Sector
Healthcare
What is the Clover Health Investments, Corp. stock price forecast?

Clover Health Investments, Corp. is currently trading at $4.73. View real-time AI analysis on Alpha Lenz.

What is Clover Health Investments, Corp. insider trading activity?

View the latest insider trading data for Clover Health Investments, Corp. on Alpha Lenz.

What is Clover Health Investments, Corp.'s P/E ratio?

Clover Health Investments, Corp.'s P/E ratio is -28.3.

Clover Health Investments, Corp.

NASDAQ · CLOV
$4.73-0.17(-3.47%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Clover Health Investments, Corp.'s future dividend policy...
Alpha Chat Insight

Clover Health Investments, Corp. trades at a P/E of -28.3 (undervalued) with modest ROE of -26.3%.

Ask for details

Company Overview

Clover Health Investments Corp. is a next-generation healthcare technology company focusing on Medicare Advantage plans. The primary purpose of Clover Health is to democratize healthcare for seniors by utilizing advanced data analytics to improve outcomes and reduce costs. By leveraging its proprietary software platform, the Clover Assistant, the company supports healthcare providers in delivering more personalized and effective care to Medicare beneficiaries. Clover Health operates predominantly in the U.S. healthcare sector, impacting various industries including medical technology, insurance, and elder care. The company aims to streamline health services and make healthcare more accessible, emphasizing preventive care and chronic disease management. By integrating technology with healthcare, Clover Health addresses inefficiencies in traditional insurance models, positioning itself as a significant player in the evolving digital health space. As part of its market role, Clover Health represents a shift towards value-based care and reflects broader industry trends of incorporating tech-driven solutions to enhance patient care. Its approach to blending technology and healthcare aligns with the increasing demand for innovative, cost-effective health services.

CEOMr. Andrew Toy
SectorHealthcare
IndustryHealthcare Plans
Employees570

Company Statistics

FY 2025

Profile

$2.42BMarket Cap
$1.92BRevenue
0.00Shares Out
570Employees

Margins

18.50%Gross
-4.36%EBITDA
-4.44%Operating
-4.45%Pre-Tax
-4.45%Net

Valuation

-28.31P/E
7.84P/B
1.26EV/Sales
-27.95EV/EBITDA
-35.11P/FCF

Growth (CAGR)

-17.89%Rev 3Yr
23.39%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-15.25%ROA
-26.33%ROE
-15.25%ROIC

Financial Health

$78.30MCash & Cash Equivalents
$154.01MNet Debt
75.25%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Clover Health Investments, Corp. (ticker: CLOV) is a company listed on NASDAQ in the Healthcare sector (Healthcare Plans). It has approximately 570 employees. Market cap is $2.4B.

The current price is $4.73 with a P/E ratio of -28.31x and P/B of 7.84x.

ROE is -26.33% and operating margin is -4.44%. Annual revenue is $1.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Clover Health Investments, Corp. (CLOV) Stock Forecast 2026 $4.73 — Price, Financials & Analyst Targets | Alpha Lenz